Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Delgocitinib Cream for Chronic Hand Eczema
Recruiting1 awardPhase 3
Fredericton
This trial tests if delgocitinib cream can effectively treat chronic hand eczema in children aged 12-17 and examines any side effects. The cream reduces inflammation by targeting specific immune responses. The study lasts several months, with children using the cream regularly. Delgocitinib ointment is a newly approved topical medication for the treatment of atopic dermatitis (AD).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service